Shares of Aytu Bioscience Inc (NASDAQ:AYTU) were up 13.8% during mid-day trading on Tuesday . The company traded as high as $1.09 and last traded at $1.07. Approximately 1,045,182 shares were traded during trading, an increase of 331% from the average daily volume of 242,536 shares. The stock had previously closed at $0.94.
Separately, Northland Securities started coverage on shares of Aytu Bioscience in a report on Monday, October 22nd. They set an “outperform” rating and a $10.00 price objective for the company.
The firm has a market capitalization of $1.69 million, a PE ratio of -0.04 and a beta of 6.25.
Aytu Bioscience Company Profile (NASDAQ:AYTU)
Aytu BioScience, Inc, a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia.
Read More: What Does Beta Mean In Stock Selection
Receive News & Ratings for Aytu Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.